Literature DB >> 2885384

Use of monoclonal antibodies to identify, characterize, and purify a 96,000-dalton surface antigen of pathogenic Entamoeba histolytica.

B E Torian, S A Lukehart, W E Stamm.   

Abstract

We identified and partially characterized a surface antigen of Entamoeba histolytica by using seven monoclonal antibodies obtained after injecting mice with a pathogenic strain of amoeba. An intrinsically radiolabeled 96,000-dalton antigen was immunoprecipitated by five of the seven monoclonal antibodies; this antigen was present in three strains of E. histolytica. The antigen was situated on the external surface of E. histolytica, as demonstrated by agglutination and immunofluorescence staining of live amoeba and by immunoprecipitation of iodinated trophozoite antigen. All seven monoclonal antibodies were specific for E. histolytica and failed to react in an ELISA with Trichomonas vaginalis, Tritrichomonas foetus, Giardia lamblia, Acanthamoeba castellonii, and Entamoeba invadens. Two monoclonal antibodies were used to purify the antigen: the purified antigen was identical when antibody binding to live organisms or antibody reactive with nonviable organisms was used for purification.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885384     DOI: 10.1093/infdis/156.2.334

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Immunoreactivity of Entamoeba histolytica antigens with sera from amoebic patients.

Authors:  R K Shandil; V K Vinayak
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

2.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

3.  Inhibition of target cell adhesion by monoclonal antibody to the 66 kD surface antigen of Entamoeba histolytica.

Authors:  H Vohra; S Kaur; A Wangoo; N K Ganguly; R C Mahajan
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

4.  Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay.

Authors:  M A Sathar; B L Bredenkamp; V Gathiram; A E Simjee; T F Jackson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.

Authors:  B M Flores; C A Garcia; W E Stamm; B E Torian
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica.

Authors:  B E Torian; B M Flores; V L Stroeher; F S Hagen; W E Stamm
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica.

Authors:  P Arhets; P Gounon; P Sansonetti; N Guillén
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture.

Authors:  A Leroy; G De Bruyne; M Mareel; C Nokkaew; G Bailey; H Nelis
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Authors:  A Gonzalez-Ruiz; R Haque; T Rehman; A Aguirre; C Jaramillo; G Castañon; A Hall; F Guhl; G Ruiz-Palacios; D C Warhurst
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates.

Authors:  S L Reed; B M Flores; M A Batzer; M A Stein; V L Stroeher; J E Carlton; D L Diedrich; B E Torian
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.